Hina Mauka- Outpatient Office

Hina Mauka- Outpatient Office, based in Waipahu, HI, is one of the SAMHSA-registered treatment programs operating in HI. The facility's programming is outpatient (IOP), not residential. What this page can help with is the frame — what to ask, what to verify, what to compare against.

Care levels at Hina Mauka- Outpatient Office

The care-level question matters because what a facility offers is what it can realistically treat well. Hina Mauka- Outpatient Office is an outpatient-focused program (IOP) — patients live at home or in sober living and attend treatment sessions. This level of care is clinically appropriate for mild-to-moderate substance use disorder, or for patients stepping down from residential. Before admission, an independent clinical assessment (from a primary-care doctor, licensed substance-use counselor, or addiction-medicine physician) can confirm whether Hina Mauka- Outpatient Office's offerings match the clinical need.

Insurance and payment

On insurance specifically: Payment and insurance specifics for Hina Mauka- Outpatient Office are not fully documented in the SAMHSA registry — a direct admissions conversation is the reliable way to confirm what forms of payment are accepted and at what network-contract level. Before admission, ask the facility's utilization-review team for a written Verification of Benefits — not verbal assurance, which is where most post-treatment financial surprises come from. Also ask for specific plan-level confirmation, not carrier-level (e.g., "your Aetna PPO plan" not just "Aetna").

Specialty programming

The facility's documented specialty programming includes: Adolescents. The specialty question rewards specific follow-up: what clinicians provide the specialty content, what their credentials are, what percentage of weekly programming is specialty-specific vs. general programming.

Before you call

Three questions to put to Hina Mauka- Outpatient Office before admission: the specific ASAM level the facility is billing; the written Verification of Benefits for your specific plan product; the MAT policy (continuation of buprenorphine or methadone during residential, specifically). If the clinical situation involves opioid use disorder, confirm explicitly whether Hina Mauka- Outpatient Office offers medication-assisted treatment — buprenorphine, methadone, or naltrexone. Programs that do not are operating outside the current standard of care. Getting answers in writing protects against the downstream surprises.